View Cart (0 items)


GlaxoSmithKline trimming US sales force by 1,000

November 5, 2008
According to the Associated Press, GlaxoSmithKline is restructuring its U.S. operations, starting with reducing its U.S. sales force by 1,000. A spokeswoman says the company also will switch from having
Read More

Biotech IPOs dying on the vine

November 3, 2008
While, the market for initial public offerings has shut down in all industries, with no deals in the United States in nearly three months, biotechnology companies desperate for capital will
Read More

Report: US drug sales growth heads toward new low

October 29, 2008
A report issued from IMS Health says that U.S. sales of pharmaceuticals will grow at the slowest rate on record this year, as the weakening economy compounds other factors
Read More

$894 million deal ends pain of Pfizer''s lawsuits

October 20, 2008
The Associated Press reports that Pfizer Inc. has reached an $894 million deal to settle the bulk of the lawsuits over its withdrawn pain reliever Bextra. The Pfizer agreement will
Read More

Synta Pharmaceuticals to get $25 million from GlaxoSmithKline

October 15, 2008
The Associated Press reports that Synta Pharmaceuticals Inc. will receive a $25 million payment from GlaxoSmithKline PLC after reaching milestones under a development agreement for the cancer drug elesclomol. The
Read More

Alabama settles suits against five drug companies

October 13, 2008
The state of Alabama has settled Medicaid drug pricing lawsuits it filed against prescription drug manufacturer Bristol-Myers Squibb and four other companies, according to the Associated Press. Bristol-Myers Squibb is
Read More

Rohm and Haas lifts force majeure for two products

October 13, 2008
The Associated Press reports that Rohm and Haas Co. has resumed full supply for some products at two Texas plants affected by Hurricane Ike in September. A plant at Deer
Read More

Lawsuit claims Pfizer suppressed Neurontin studies

October 8, 2008
Reuters has reported that documents submitted in a U.S. lawsuit against Pfizer Inc. claim the company tried to internally suppress medical studies that did not support the use of its
Read More

ImClone accepts $6 billion-plus buyout bid from Lilly

October 6, 2008
According to the Associated Press, Eli Lilly & Co. has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that will expand Lilly''s
Read More

Molecular Insight names 4 new directors to board

September 22, 2008
Biotechnology company Molecular Insight Pharmaceuticals Inc. has added four new directors to its board, including employees of GlaxoSmithKline PLC and Novartis AG, the Associated Press reported. The company named David
Read More